Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition.

A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature. 2013 Dec 05; 504(7478):138-42.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.